期刊文献+

MicroRNAs与心血管疾病的相关性研究 被引量:1

Correlation between MicroRNAs and cardiovascular diseases
下载PDF
导出
摘要 MicroRNAs(miRNAs)是一类高度保守的内源性非编码单链小分子RNA,通过降解mRNA或抑制蛋白质翻译而调控基因的表达。已有大量研究证明miRNA在心血管疾病病因、进展、诊断及治疗方面具有重要作用,现对miRNAs与心血管疾病相关性的研究进展作一综述。 MicroRNAs (miRNAs)is a kind of highly conserved endogenous un-encoded single chain micromolecule RNA, Which modulates gene expression via degrading mRNA or inhibiting protein translation. A lot of researches have proved that miRNA plays an important role in cause,development,diagnosis and treatment of cardiovascular diseases.This article made an overvieW on research progress for correlation betWeen miRNAs and cardiovascular diseases.
出处 《心血管康复医学杂志》 CAS 2014年第2期230-233,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 微RNAS 心血管疾病 心肌梗塞 MicroRNAs Cardiovascular diseases Myocardial infarction
  • 相关文献

参考文献14

  • 1Lee RC, Feinbaum RL, Ambros V. The C. elegans hetero- chronic gene lin-4 encodes small RNAs with antisense comple mentaritytolin-14 [J]. Cell, 1993, 75 (5) : 843-854.
  • 2Cheng Y, Tan N, Yang J, et al. A translational study of circu lating cell-free MicroRNA- 1 in acute myocardial infarction [J]. Clin Sci (Lond), 2010, 119 (2): 87-95.
  • 3Adachi T, Nakanishi M, Otsuka Y, et al. Plasma MicroRNA 499 as a biomarker of acute myocardial infarction [J]. Clin Chem, 2010, 56 (7): 1183-1185.
  • 4Wang R, L i N, Zhang Y, et al. Circulating MicroRNAs arepromising novel biomarkers of acute myocardial infarction [J]. Internal Med, 2011, 50 (17): 1789-1795.
  • 5Wang GK, Zhu JQ, Zhang JT, et al. Circulating MicroRNA: a novel potential biomarker for early diagnosis of acute myocardi- al infarction in humans [J]. Eur Heart J, 2010, 31 (6): 659 -666.
  • 6Terentyev D, Belevych AE, Terentyeva R, et al. miR- 1 overexpression enhances Ca2+ release and promotes cardiac ar- rhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2 [J]. CircRes, 2009, 104 (4): 514-521.
  • 7Xiao J, Luo X, Lin H, et al. MicroRNA miR-133 represses HERG K- channel expression contributing to QT prolongation in diabetic hearts [J].J Biol Chem, 2007, 282 (17) : 12363- 12367.
  • 8Lu Y, Zhang Y, Wang N, et al. MicroRNA 328 contributes to adverse electrical remodeling in atrial fibrillation [J]. Circula tion, 2010, 122 (23): 2378-2387.
  • 9Li S, Zhu J, Zhang W, et al. Signature MicroRNA expression profile of essential hypertension and its novel link to human cyto[J]. Circulation, 2011, 124 (2): 175.
  • 10Suckau L, Feehner H, Chemaly E, et al. Long-term cardiac- targeted RNA interference for the treatment of heart failure re- stores cardiac function and reduces pathological hypertrophy [J]. Circulation, 2009, 119 (9): 1241-1252.

二级参考文献26

  • 1Galie N,Olschewski H,Oudiz R J,et al.Ambrisentan for the treatment of pulmonary arterial hypertension:results of the ambrisentan in pulmonary arterial hypertension,randomized,double-blind,placebo-controlled,multicenter,efficacy(ARIES)study 1 and 2.Circulation,2008,117(23):3010-3019.
  • 2Olschewski H.[Dana Point:what is new in the diagnosis of pulmonary hypertension?.Dtsch Med Wochenschr,2008,133 Suppl 6:S180-S182.
  • 3Du T,Zamore P D.microPrimer:the biogenesis and function of microRNA.Development,2005,132(21):4645-4652.
  • 4Zhu W,Qin W,Atasoy U,et al.Circulating microRNAs in breast cancer and healthy subjects.BMC Res Notes,2009,2:89.
  • 5Cheng Y,Tan N,Yang J,et al.A translational study of circulating cell-free microRNA-I in acute myocardial infarction.Clin Sci(Lond),2010,119(2):87-95.
  • 6Rabinovitch M.Molecular pathogenesis of pulmonary arterial hypertension.J Clin Invest,2008,118(7):2372-2379.
  • 7Archer S L,Gomberg-Maitland M,Maitland M L,et al.Mitochondrial metabolism,redox signaling,and fusion:a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.Am J Physiol Heart Cite Physiol,2008,294(2):H570-H578.
  • 8Archer S L,Marsboom G,Kim G H,et al.Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension:a basis for excessive cell proliferation and a new therapeutic target.Circulation,2010,121(24):2661-2671.
  • 9Klooeterman W P,Plasterk R H.The diverse functions of microRNAs in animal development and disease.Dev Cell,2006,11(4):441-450.
  • 10Mendell J T.MicroRNAs:critical regulators of development,cellular physiology and malignancy.Cell Cycle,2005,4(9):1179-1184.

共引文献11

同被引文献18

  • 1张莹莹,郭绪昆.心血管疾病标志物的新秀:循环microRNA[J].医学信息(医学与计算机应用),2014,0(17):674-676. 被引量:2
  • 2Small EM,Olson EN.Peyvasive roles of microRNAs in cardiovascular biology[J].Nature,2011,469(7330):336-342.
  • 3Chim SS,Shing TK,Hung EC,et al.Detection and characterization of placental microRNAs in maternal plasma[J].Clin Chem,2008,54(3):482-490.
  • 4Weber JA,Baxter DH,Zhang S,et al.The microRNA spectrum in 12 body fluids[J].Clin Chem,2010,56(11):1733-1741.
  • 5Boon RA,Vickers KC.Intercellular transport of microRNAs[J].Arterioscler Thromb Vasc Biol,2013,33(2):186-192.
  • 6Kim DH,Saetyom P,Smove O Jr,et al.MicroRNA-directed transcriptional gene silencirg in mammalian celk[J].Proc Natl Acad Sci U SA,2008,105(42):16230-16235.
  • 7Tay Y,Zhang J,Thomson AM,et al.MicroRNAs to Nanog,Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation [J].Nature,2008,455(7216):1124-1128.
  • 8Callis TE,Pandya K,Seok HY,et al.MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice[J].J Clin Invest,2009,119(9):2772-2786.
  • 9Satoh M,Minami Y,Takahashi Y,et al.Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy[J].J Card Fail,2010,16(5);404-410.
  • 10Da Costa Martins PA,De Windt LJ.MicroRNAs in control of cardiac hypertrophy[J].Cardiovasc Res,2012,93(4):563-572.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部